Timeline
Giovanna Barba-Spaeth
Group Leader
24 Feb 2024
publication
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection.
Read more21 Aug 2023
publication
New insight into flavivirus maturation from structure/function studies of the yellow fever virus envelope protein complex
Read more09 Aug 2023
08 Mar 2023
02 Feb 2023
02 Jan 2023
publication
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination.
Read more22 Jul 2022
22 Jul 2022
14 Jun 2022
publication
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant.
Read more01 Apr 2022
01 Jan 2022
publication
FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D.
Read more14 Dec 2021
publication
mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants.
Read more16 Apr 2021
publication
Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts.
Read more04 Mar 2021
01 Sep 2020
project
Understanding protective humoral immunity in asymptomatic dengue-infected individuals
Read more01 May 2020
publication
Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination.
Read more24 Mar 2020
publication
Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine.
Read more23 May 2017
publication
Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope.
Read more01 Nov 2016
publication
Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses.
Read more01 Sep 2016
publication
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
Read more23 Jun 2016
11 Sep 2015
11 May 2015
02 Apr 2015
publication
Recognition determinants of broadly neutralizing human antibodies against dengue viruses.
Read more15 May 2011
publication
Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.
Read more23 Jun 2010
publication
Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii.
Read more01 Dec 2006
publication
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
Read more31 Oct 2005
publication
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes.
Read more17 Jan 2005
publication
Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model.
Read more01 Feb 2002
publication
Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis.
Read more01 Oct 1999
publication
Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates.
Read more01 May 1999
publication
Permissiveness of human biliary epithelial cells to infection by hepatitis C virus.
Read more18 Feb 1997
publication
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets.
Read more01 Oct 1994
publication
A new PCR-based typing of the Rodgers and Chido antigenic determinants of the fourth component of human complement.
Read more01 Jul 1994
publication
Polymorphism of the complement C8A and -B genes in two families with C8 beta deficiency and neisserial infections.
Read more01 Apr 1993
publication
Genetic basis of human complement C4A deficiency. Detection of a point mutation leading to nonexpression.
Read more05 Jul 1990
01 Jan 1990
publication